The evolving field of kinase inhibitors in thyroid cancer.
about
Lenvatinib enhances the antitumor effects of paclitaxel in anaplastic thyroid cancerFasting potentiates the anticancer activity of tyrosine kinase inhibitors by strengthening MAPK signaling inhibition.miR-195 is a key regulator of Raf1 in thyroid cancer.Thyroglobulin fluctuations in patients with iodine-refractory differentiated thyroid carcinoma on lenvatinib treatment - initial experience.Efficacy and Safety of Everolimus in Extrapancreatic Neuroendocrine Tumor: A Comprehensive Review of Literature.Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma.Kinase-targeted cancer therapies: progress, challenges and future directions.Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib.Complete disappearance of liver metastases in a patient with iodine-refractory differentiated thyroid cancer subjected to sorafenib re-challenge.
P2860
Q33622678-45D9EBDE-CFB6-4852-961E-D79CBE0680C4Q35828447-2DC981FF-67E8-46DF-A43F-A6B0FAEC8650Q36208479-C673D591-6C0B-4EC1-AEE9-617A50CA19CAQ37010592-D73EA824-B0F5-4EAF-B262-2A51515D3381Q37091117-AB82290E-A110-4181-8379-9425570A181DQ38798863-13A6B2FC-1785-495E-8F08-147E551F8A7FQ49887882-9A14BDF1-9994-4145-8A4B-B1879FCD0E31Q54280978-B654284E-B034-4833-99E8-A35A6E5031EEQ54285618-70402979-56CD-4CBC-AE0D-032D67486FDB
P2860
The evolving field of kinase inhibitors in thyroid cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
The evolving field of kinase inhibitors in thyroid cancer.
@en
type
label
The evolving field of kinase inhibitors in thyroid cancer.
@en
prefLabel
The evolving field of kinase inhibitors in thyroid cancer.
@en
P2093
P1476
The evolving field of kinase inhibitors in thyroid cancer.
@en
P2093
P356
10.1016/J.CRITREVONC.2014.08.007
P577
2014-09-16T00:00:00Z